title: A study of gemcitabine, l-asparaginase, ifosfamide, dexamethasone and etoposide chemotherapy for newly diagnosed stage IV, relapsed or refractory extranodal natural killer/T-cell lymphoma, nasal type.
authors.affiliation: Department of Hematology, West China Hospital of Sichuan University , Chengdu , China.
authors.forename: Jie
authors.initials: J
authors.lastname: Ji
authors.forename: Ting
authors.initials: T
authors.lastname: Liu
authors.forename: Bing
authors.initials: B
authors.lastname: Xiang
authors.forename: Weiping
authors.initials: W
authors.lastname: Liu
authors.forename: Chuan
authors.initials: C
authors.lastname: He
authors.forename: Xinchuan
authors.initials: X
authors.lastname: Chen
authors.forename: Jianjun
authors.initials: J
authors.lastname: Li
authors.forename: Hong
authors.initials: H
authors.lastname: Chang
authors.forename: Yang
authors.initials: Y
authors.lastname: Dai
authors.forename: Tian
authors.initials: T
authors.lastname: Dong
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001215:Asparaginase / Q000008:administration & dosage; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D003907:Dexamethasone / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D054391:Lymphoma, Extranodal NK-T-Cell / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology*; D009364:Neoplasm Recurrence, Local; D016896:Treatment Outcome; D000093542:Gemcitabine
chemical_list: D003841:Deoxycytidine; D005047:Etoposide; D003907:Dexamethasone; D001215:Asparaginase; D007069:Ifosfamide; D000093542:Gemcitabine